Emergent Health Overview
Get informed when a big investor buys or sells
+ Follow19.86%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for EMGE is 19.86%. That is above the sector sector average of 11.64%. Investors often review this figure alongside Emergent Health's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, EMGE currently prints 19.86% for ROE, while the sector average sits near 11.64%. That is roughly 70.7% above the sector mean. Large gaps often invite a closer look at Emergent Health's growth, margins, and balance sheet.
Return on Equity shows how effectively Emergent Health converts resources into returns. At 19.86%, EMGE may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting EMGE's ROE (19.86%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
